Natera (NTRA) Announces Publication of Findings from Randomized, Phase III CALGB (Alliance)/SWOG 80702 Study

Natera, Inc. (NASDAQ:NTRA) is 1 of the High Growth Large Cap Stocks to Buy Right Now. On December 18, the institution announced work of the findings from the randomized, signifier III CALGB (Alliance)/SWOG 80702 survey in JAMA Oncology. CALGB (Alliance)/SWOG 80702 assessed predictive worth of postoperative personalized circulating tumor DNA (ctDNA) successful patients having signifier III colorectal crab (CRC).

Furthermore, it was mentioned that, for patients having detectable ctDNA aft surgery, the summation of celecoxib to modular chemotherapy improved some DFS and OS. Apart from highlighting Signatera’s predictive abilities successful the setting, the work underscores its worth arsenic a prognostic marker for illness recurrence and survival.

In a abstracted update, connected December 17, Jefferies lifted the terms nonsubjective connected the company’s banal to $275.00 from $230.00, portion maintaining a “Buy” rating. The steadfast cited Natera, Inc. (NASDAQ:NTRA)’s accordant signifier of surpassing expectations and raising guidance. Notably, the steadfast besides noted accrued mean selling terms from commercialized coverage, caller indications, arsenic good arsenic guidelines arsenic the maturation factors, with American College of Obstetricians and Gynecologists (ACOG) perchance acting arsenic a catalyst for non-invasive prenatal investigating (NIPT).

Elsewhere, Natera, Inc. (NASDAQ:NTRA), on with Quantum Leap Healthcare Collaborative, announced astir work of caller findings from the I-SPY 2 proceedings in Nature Communications. Notably, the survey assessed however Signatera tin refine hazard appraisal successful patients having early-stage bosom crab whose tumors defy neoadjuvant therapy (NAT).

Natera, Inc. (NASDAQ:NTRA) happens to beryllium a planetary person successful cell-free DNA and precision medicine, dedicated to oncology, women’s health, and organ health.

While we admit the imaginable of NTRA arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest successful Now

Disclosure: None. This nonfiction is primitively published at Insider Monkey.